Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology.
cancer biology
human
methodology
mouse
null results
open science
replication
reproducibility
transparency
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
07 12 2021
07 12 2021
Historique:
received:
31
08
2021
accepted:
14
11
2021
entrez:
7
12
2021
pubmed:
8
12
2021
medline:
16
12
2021
Statut:
epublish
Résumé
As part of the Reproducibility Project: Cancer Biology, we published Registered Reports that described how we intended to replicate selected experiments from 29 high-impact preclinical cancer biology papers published between 2010 and 2012. Replication experiments were completed and Replication Studies reporting the results were submitted for 18 papers, of which 17 were accepted and published by
Identifiants
pubmed: 34874009
doi: 10.7554/eLife.73430
pii: 73430
pmc: PMC8651290
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P30 CA030199
Pays : United States
Informations de copyright
© 2021, Errington et al.
Déclaration de conflit d'intérêts
TE Employed by the nonprofit Center for Open Science that has a mission to increase openness, integrity, and reproducibility of research, AD Was employed by the nonprofit Center for Open Science that has a mission to increase openness, integrity, and reproducibility of research, AA, KH No competing interests declared, RA, LB, JC, SD, TT, BW, JW Employed by the University of California, Davis Mouse Biology Program, a Science Exchange associated lab during experimentation, PA Was employed by Cancer Metabolism Facility at Sanford Burnham Prebys Medical Discovery Institute, a Science Exchange associated lab during experimentation, HC, JK, VS, AT, LY Employed by Applied Biological Materials, a Science Exchange associated lab during experimentation, CD, BH, EM, MS Was employed by TGA Sciences, a Science Exchange associated lab during experimentation, EI Employed by and hold shares in Science Exchange Inc, SP Employed by Kinexus Bioinformatics Corporation, a Science Exchange associated lab during experimentation, NP, RT Was employed by and hold shares in Science Exchange Inc, AP Was employed by Applied Biological Materials, a Science Exchange associated lab during experimentation, DS Employed by BioFactura, a Science Exchange associated lab during experimentation, DS Employed by Cancer Metabolism Facility at Sanford Burnham Prebys Medical Discovery Institute, a Science Exchange associated lab during experimentation
Références
PLoS One. 2017 Mar 28;12(3):e0174461
pubmed: 28350845
Elife. 2015 Jan 26;4:
pubmed: 25621566
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
Cell. 2010 Jan 22;140(2):209-21
pubmed: 20141835
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Elife. 2016 Mar 11;5:e10860
pubmed: 26971564
Elife. 2014 Dec 10;3:
pubmed: 25490933
Nature. 2011 Nov 09;479(7374):547-51
pubmed: 22080947
Cell. 2010 Apr 2;141(1):69-80
pubmed: 20371346
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14903-8
pubmed: 20668238
Pigment Cell Melanoma Res. 2010 Apr;23(2):190-200
pubmed: 20149136
Nature. 2010 Aug 12;466(7308):869-73
pubmed: 20668451
Elife. 2016 Feb 16;5:
pubmed: 26882073
Trends Cancer. 2019 Mar;5(3):170-182
pubmed: 30898264
Cancer Cell. 2013 May 13;23(5):594-602
pubmed: 23680146
Eur Neuropsychopharmacol. 2019 Dec;29(12):1312-1320
pubmed: 31753777
Elife. 2021 Dec 07;10:
pubmed: 34874008
Nat Commun. 2016 Feb 19;7:10690
pubmed: 26891683
PLoS Biol. 2019 Feb 21;17(2):e3000151
pubmed: 30789895
Nature. 2010 Dec 9;468(7325):829-33
pubmed: 21102433
Front Oncol. 2019 Mar 29;9:194
pubmed: 30984620
PLoS Med. 2005 Jan;2(1):e17
pubmed: 15696205
Nature. 2010 Dec 9;468(7325):824-8
pubmed: 21102434
Elife. 2016 Feb 19;5:
pubmed: 26894955
Elife. 2015 Feb 25;4:
pubmed: 25714925
Elife. 2015 Jun 18;4:e06938
pubmed: 26086719
PLoS One. 2017 Oct 5;12(10):e0185862
pubmed: 28982154
Cancer Cell. 2018 Aug 13;34(2):186-195
pubmed: 29805076
Gene. 2018 Jul 30;665:67-73
pubmed: 29709639
Elife. 2016 Feb 17;5:
pubmed: 26885666
Pharm Stat. 2011 Mar-Apr;10(2):128-34
pubmed: 22328315
Medicine (Baltimore). 2017 Nov;96(47):e8487
pubmed: 29381923
Nature. 2010 Mar 18;464(7287):427-30
pubmed: 20179705
BMC Cancer. 2018 May 8;18(1):542
pubmed: 29739364
Nature. 2010 Dec 16;468(7326):968-72
pubmed: 21107320
Mol Cancer Ther. 2015 Dec;14(12):2700-11
pubmed: 26351322
Cell. 2013 Mar 28;153(1):139-52
pubmed: 23540695
Cell Prolif. 2017 Jun;50(3):
pubmed: 28319306
Elife. 2016 Feb 23;5:
pubmed: 26905833
Elife. 2021 Dec 07;10:
pubmed: 34874005
Hum Mol Genet. 2011 Apr 15;20(R1):R14-20
pubmed: 21459777
Nature. 2010 Mar 18;464(7287):431-5
pubmed: 20130576
Elife. 2014 Dec 10;3:
pubmed: 25490934
Elife. 2016 Mar 21;5:
pubmed: 26999821
Nat Chem Biol. 2013 Jul;9(7):428-36
pubmed: 23685672
Front Immunol. 2019 May 07;10:990
pubmed: 31134073
Mod Pathol. 2017 Jul;30(7):952-963
pubmed: 28338653
BMC Med Genomics. 2019 Apr 15;12(1):54
pubmed: 30987631
Oncol Lett. 2017 Mar;13(3):1665-1671
pubmed: 28454307
Biochem Pharmacol. 2019 Apr;162:169-176
pubmed: 30414937
Elife. 2015 Jul 31;4:e07420
pubmed: 26231040
Database (Oxford). 2016 Jul 03;2016:
pubmed: 27374120
Elife. 2014 Dec 10;3:
pubmed: 25490932
Cell Rep. 2016 Nov 22;17(9):2234-2246
pubmed: 27880900
Elife. 2020 May 22;9:
pubmed: 32441650
Cancer Res. 2004 Dec 15;64(24):9101-4
pubmed: 15604279
Nature. 2017 Aug 10;548(7666):239-243
pubmed: 28783725
Science. 2014 Sep 19;345(6203):1502-5
pubmed: 25170047
J Pathol Transl Med. 2016 Nov;50(6):411-418
pubmed: 27809448
Nature. 2012 Feb 15;483(7390):474-8
pubmed: 22343901
Oncotarget. 2017 Feb 7;8(6):9251-9266
pubmed: 27999210
Int J Biochem Cell Biol. 2016 Oct;79:249-260
pubmed: 27594411
Nature. 2017 Aug 10;548(7666):234-238
pubmed: 28783719
Cancer Discov. 2019 May;9(5):587-604
pubmed: 30992280